US and European Interventional Oncology Devices Market Assessment for Breast Cancer, Forecast to 2020

US and European Interventional Oncology Devices Market Assessment for Breast Cancer, Forecast to 2020

Improving Treatment Efficacy through Minimally Invasive Interventions is Driving the Demand for Interventional Procedures

RELEASE DATE
17-Sep-2019
REGION
North America
Research Code: MD8F-01-00-00-00
SKU: HC03218-NA-MR_23603

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03218-NA-MR_23603

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The research service provides an overview of the interventional oncology devices market for breast cancer in big five countries in Europe and in the United States. The study provides a four-year forecast from 2016 to 2020. The unique value of this study is that it provides insights gathered from more than 100 end users, including Interventional radiologists, interventional oncologists, and breast surgeons. The segments include ablation devices (primarily radiofrequency, cryo, and microwave), high-intensity–focused ultrasound (HIFU), and embolization devices, which include microcatheters, balloon catheter, microspheres, radioembolization spheres, PVA particles, embolic coils, chemo-embolization, gelatin sponge, bioabsorbable products, and drug-eluting beads.

Breast cancer surgical treatment has evolved from the days of the radical mastectomy to breast conservation surgery. However, over the last 5 years, there has been a stipulated increase in adoption for percutaneous treatment modalities for breast cancer instead of surgery. These modalities include cryoablation, radiofrequency ablation, microwave ablation, laser ablation, and ultrasound ablation. There are also the newest kinds of HIFU and embolization techniques that are used to treat tumors with precision. The biggest advantage is that most of these procedures are outpatient procedure and require minimal time for conducting the procedure. These segments are changing the dynamics of cancer therapies. Hospitals and manufacturers are interested in knowing the adoption potential of various products across different applications of cancer such as lung, liver, and breast cancers. This study focuses only on breast cancer. It is interesting to note that breast cancer has adoption of these interventions despite established care treatment paradigm. The biggest drawback and concern for this market is lack of reimbursement and insufficient clinical data to increase the scalability of the adoption of these procedures. However, interestingly, the adoption has been seen in a significant way for select anatomies of cancer, and this likely to drive the growth across all other cancer types too in the short term.

This study provides infrastructure details, procedure statistics, revenue forecasts, and competitive analysis across countries. The geographic areas covered in the study include the US, Germany, France, Italy, Spain and the UK. These regions have been on focus primarily because of the increased awareness of benefits of the adoption of these technologies and their ability to spend on new technologies and training for the surgeons to use the same. The base year for the study is 2017 and revenue forecasts have been provided until 2020.

Table of Contents

Executive Summary—Interventional Oncology Devices Market for Breast Cancer

Research Scope and Segmentation

Infrastructure Summary

Ablation Devices Market for Breast Cancer—Overview

Ablation Procedure and Market for Breast Cancer—Comparison of Europe and US

Ablation Procedure and Market Breast Cancer—Comparison of Europe and US (continued)

Radiofrequency Ablation Device Market for Breast Cancer—Comparison of Europe and US

Cryoablation Procedure and Market Comparison—Europe and US

Microwave Ablation Devices for Breast Cancer—Comparison of Europe and US

Ablation Devices Market for Breast Cancer—Europe and US Market Summary

HIFU Devices Market Overview

Embolization Devices Market Overview

Total HIFU and Embolization Devices Market for Breast Cancer—Comparison of Europe and US

Total Interventional Procedures for All Cancer Versus Breast Cancer Procedures by Ablation

Total Breast Cancer Procedures by Type of Radiation Therapy and Image-guided Modalities

Total Breast Cancer Procedures by Type of Radiation Therapy and Image-guided Modalities (continued)

Ablation Devices Market for All Cancers and Breast Cancer in US

Competitive Analysis for Ablation Devices Market for Breast Cancer in US

HIFU Devices Market for All Cancer and Breast Cancer in US

Embolization Devices Market for All Cancer and Breast Cancer in US

Competitive Analysis for Embolization Devices Market for Breast Cancer in US

Factors Influencing Ablation Device Adoption in Clinical Settings

Factors Influencing Adoption of Interventional Devices

Product Price Trends and Impact on Procurement

Product Price Trends and Impact on Procurement (continued)

Service Capabilities and Offerings by Manufacturers

Patient Referral Trends and Medical Conferences

Total Interventional Procedures for All Cancer Versus Breast Cancer Procedures by Ablation Devices

Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities

Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities (continued)

Ablation Market for All Cancer and Breast Cancer in UK

Competitive Analysis for Ablation Devices Market for Breast Cancer in UK

HIFU Devices Market Analysis and Competitive Landscape in the UK

Embolization Market Analysis and Competitive Landscape in UK

Factors Influencing Ablation Device Adoption in Clinical Settings

Factors Influencing Interventional Device Adoption in Clinical Settings

Product Price Trends and Impact on Procurement

Product Price Trends and Impact on Procurement (continued)

Service Capabilities and Offerings by Manufacturers

Patient Referral Trends and Medical Conferences

Total Interventional Procedures for All Cancer Versus Breast Cancer Procedures by Ablation

Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities

Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities (continued)

Ablation Devices Market for All Cancer and Breast Cancer in UK

Competitive Analysis for Ablation Market for Breast Cancer in France

HIFU Devices Market Analysis and Competitive Landscape in the France

HIFU Devices Market Analysis and Competitive Landscape in France

Factors Influencing Ablation Device Adoption in Clinical Settings

Factors Influencing Interventional Device Adoption in Clinical Settings

Product Price Trends and Impact on Procurement

Product Price Trends and Impact on Procurement (continued)

Service Capabilities and Offerings by Manufacturers

Patient Referral Trends and Medical Conferences

Total Interventional Procedures for All Cancer Versus Breast Cancer Procedures by Ablation

Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities

Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities (continued)

Ablation Market for All Cancer and Breast Cancer in Germany

Competitive Analysis for Ablation Devices Market for Breast Cancer in Germany

HIFU Devices Market Analysis and Competitive Landscape in the Germany

Embolization Devices Market Analysis and Competitive Landscape in Germany

Factors Influencing Ablation Device Adoption in Clinical Settings

Factors Influencing Interventional Device Adoption in Clinical Settings

Product Price Trends and Impact on Procurement

Product Price Trends and Impact on Procurement (continued)

Service Capabilities and Offerings by Manufacturers

Patient Referral Trends and Medical Conferences

Total Interventional Procedures for All Cancer Versus Breast Cancer Procedures by Ablation

Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities

Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities (continued)

Ablation Market for All Cancer and Breast Cancer in Italy

Competitive Analysis for Ablation Devices Market for Breast Cancer in Italy

HIFU Market Analysis and Competitive Landscape in Italy

Embolization Devices Market Analysis and Competitive Landscape in Italy

Factors Influencing Ablation Device Adoption in Clinical Settings

Factors Influencing Interventional Device Adoption in Clinical Settings

Product Price Trends and Impact on Procurement

Product Price Trends and Impact on Procurement (continued)

Service Capabilities and Offerings by Manufacturers

Patient Referral Trends and Medical Conferences

Total Interventional Procedures for All Cancer Versus Breast Cancer Procedures by Ablation

Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities

Total Breast Cancer Procedures by Type Radiation Therapy and Image-guided Modalities (continued)

Ablation Market for All Cancer and Breast Cancer in Spain

Competitive Analysis for Ablation Market for Breast Cancer in Spain

HIFU Devices Market Analysis and Competitive Landscape in Spain

Embolization Devices Market Analysis and Competitive Landscape in Spain

Factors Influencing Ablation Device Adoption in Clinical Settings

Factors Influencing Interventional Device Adoption in Clinical Settings

Product Price Trends and Impact on Procurement

Product Price Trends and Impact on Procurement (continued)

Service Capabilities and Offerings by Manufacturers

Patient Referral Trends and Medical Conferences

Growth Opportunity—Collaborations and Partnerships from Vendors

Strategic Imperatives

The Last Word—3 Big Predictions

Legal Disclaimer

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
The research service provides an overview of the interventional oncology devices market for breast cancer in big five countries in Europe and in the United States. The study provides a four-year forecast from 2016 to 2020. The unique value of this study is that it provides insights gathered from more than 100 end users, including Interventional radiologists, interventional oncologists, and breast surgeons. The segments include ablation devices (primarily radiofrequency, cryo, and microwave), high-intensity–focused ultrasound (HIFU), and embolization devices, which include microcatheters, balloon catheter, microspheres, radioembolization spheres, PVA particles, embolic coils, chemo-embolization, gelatin sponge, bioabsorbable products, and drug-eluting beads. Breast cancer surgical treatment has evolved from the days of the radical mastectomy to breast conservation surgery. However, over the last 5 years, there has been a stipulated increase in adoption for percutaneous treatment modalities for breast cancer instead of surgery. These modalities include cryoablation, radiofrequency ablation, microwave ablation, laser ablation, and ultrasound ablation. There are also the newest kinds of HIFU and embolization techniques that are used to treat tumors with precision. The biggest advantage is that most of these procedures are outpatient procedure and require minimal time for conducting the procedure. These segments are changing the dynamics of cancer therapies. Hospitals and manufacturers are interested in knowing the adoption potential of various products across different applications of cancer such as lung, liver, and breast cancers. This study focuses only on breast cancer. It is interesting to note that breast cancer has adoption of these interventions despite established care treatment paradigm. The biggest drawback and concern for this market is lack of reimbursement and insufficient clinical data to increase the scalability of the adoption of these procedures. However, interestingly, the adoption has been seen in a significant way for select anatomies of cancer, and this likely to drive the growth across all other cancer types too in the short term. This study provides infrastructure details, procedure statistics, revenue forecasts, and competitive analysis across countries. The geographic areas covered in the study include the US, Germany, France, Italy, Spain and the UK. These regions have been on focus primarily because of the increased awareness of benefits of the adoption of these technologies and their ability to spend on new technologies and training for the surgeons to use the same. The base year for the study is 2017 and revenue forecasts have been provided until 2020.
More Information
No Index No
Podcast No
Author Sowmya Rajagopalan
Industries Healthcare
WIP Number MD8F-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9A47-B1,9A48-B1,9A4B-B1